The landscape of diabetes care is changing with the introduction of skin-applied GLP-1 therapy. These innovative devices offer a potentially less invasive alternative to injections for individuals managing diabetes 2. Such a system deliver a GLP-1 agonist directly through the skin , avoiding the need for frequent injections and possibly enhancin… Read More